Skip to main content

Table 1 Trial process chart

From: The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial

 

Before baseline screening

Baseline

Visit 1 treatment phase

Visit 2 treatment phase

Visit 3 treatment phase

Visit 4 treatment phase

Visit 5 follow-up phase

 

(before chemo)

Before 2nd chemo

Before 3rd chemo

Before 4th chemo

Before 5th chemo

1 month after chemo

Patients

 Inclusion and exclusion criteria

×

      

 Informed consent

 

×

     

 Demographics

 

×

     

 Medical characteristics

×

×

×

×

×

×

×

 Randomization and allocation concealment

 

×

     

Primary outcomes

 Grading of hair loss

 

×

×

×

×

×

×

Objective indices (hair quality and hair follicles)

 

×

×

×

×

×

×

Secondary outcomes

 Facial color and thumbnail color

 

×

×

×

×

×

×

 Grading of thumbnail ridging

 

×

×

×

×

×

×

 Quality of life and fatigue

 

×

×

×

×

×

×

 Routine blood test

 

×

×

×

×

×

×

 Liver function (ALT, AST, total protein, and Alba)

 

×

×

×

×

×

×

 Renal function (Cr, UA and BUN)

 

×

×

×

×

×

×

 Kidney deficiency (IgM, C3、CD4 +, CD8 + Mg2+, Cu2+, Zn2+, Fe3+)

 

×

 

×

 

×

 

Adverse events

  

×

×

×

×

×

Patients’ diary records

  

Every day during the study

  1. BUN blood urea nitrogen, Cr creatinine, ALT alanine aminotransferase, AST aspartate aminotransferase